OpGen, Inc. (OTC:OPGN – Get Free Report)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.73 and traded as high as $5.03. OpGen shares last traded at $4.95, with a volume of 2,624 shares.
OpGen Price Performance
The business has a 50 day moving average of $0.73 and a 200 day moving average of $3.05. The firm has a market capitalization of $49.85 million, a price-to-earnings ratio of -0.89 and a beta of -1.77.
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Recommended Stories
- Five stocks we like better than OpGen
- What Does Downgrade Mean in Investing?
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Transportation Stocks Investing
- Amazon Is One of the Clearest Buys If the Market Dips Again
- What to Know About Investing in Penny Stocks
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
